Immatics (IMTX) Cash from Investing Activities (2019 - 2025)

Immatics recorded quarterly Cash from Investing Activities of -$33.7 million in Q4 2025, down 123.48% quarter-over-quarter from $143.4 million in Q3 2025, and up 33.55% year-over-year from -$25.2 million in Q4 2024.

Immatics' Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$33.7 million for Q4 2025.

  • In Q4 2025, Cash from Investing Activities rose 33.55% year-over-year to -$33.7 million; the TTM figure through Dec 2025 stood at $231.7 million (up 240.78% YoY), while the FY2025 annual figure was $231.4 million, up 242.08% from the prior year.
  • Cash from Investing Activities came in at -$33.7 million for Q4 2025 at Immatics, down from $143.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $143.4 million in Q3 2025 to a low of -$262.7 million in Q1 2024.
  • A 5-year average of -$8.7 million and a median of -$3.0 million in 2023 frame the typical range for Cash from Investing Activities.
  • On a YoY basis, Cash from Investing Activities climbed as much as 510.15% in 2024 and fell as far as 6481.11% in 2024.
  • Immatics' Cash from Investing Activities stood at -$2.1 million in 2021, then tumbled by 4300.84% to -$92.0 million in 2022, then soared by 169.84% to $64.3 million in 2023, then tumbled by 178.82% to -$50.7 million in 2024, then soared by 33.55% to -$33.7 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$33.7 million, $143.4 million, and $72.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -2.89 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 638.50 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -431.90 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -428.90 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -25.54 Mn
10 Immatics 1.80 Bn 1.80 Bn - -33.66 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -33.66 Mn
Dec 31, 2025 -33.66 Mn
Sep 30, 2025 143.39 Mn
Sep 30, 2025 143.39 Mn
Jun 30, 2025 72.73 Mn
Jun 30, 2025 72.73 Mn
Mar 31, 2025 49.24 Mn
Mar 31, 2025 49.24 Mn
Dec 31, 2024 -50.66 Mn
Dec 31, 2024 -50.66 Mn
Sep 30, 2024 73.59 Mn
Sep 30, 2024 73.59 Mn
Jun 30, 2024 75.19 Mn
Jun 30, 2024 75.19 Mn
Mar 31, 2024 -262.70 Mn
Mar 31, 2024 -262.70 Mn
Dec 31, 2023 64.27 Mn
Dec 31, 2023 64.27 Mn
Sep 30, 2023 -76.82 Mn
Sep 30, 2023 -76.82 Mn
Jun 30, 2023 -18.33 Mn
Jun 30, 2023 -18.33 Mn
Mar 31, 2023 -3.99 Mn
Mar 31, 2023 -3.99 Mn
Dec 31, 2022 -92.03 Mn
Dec 31, 2022 -92.03 Mn
Sep 30, 2022 -71.65 Mn
Sep 30, 2022 -71.65 Mn
Jun 30, 2022 -58.01 Mn
Jun 30, 2022 -58.01 Mn
Mar 31, 2022 6.55 Mn
Mar 31, 2022 6.55 Mn
Dec 31, 2021 -2.09 Mn
Dec 31, 2021 -2.09 Mn
Sep 30, 2021 23.15 Mn
Sep 30, 2021 23.15 Mn
Jun 30, 2021 -15.49 Mn
Jun 30, 2021 -15.49 Mn
Mar 31, 2021 3.09 Mn
Mar 31, 2021 3.09 Mn
Dec 31, 2020 -474,531.36
Dec 31, 2020 -474,531.36
Sep 30, 2020 -31.56 Mn
Sep 30, 2020 -31.56 Mn
Jun 30, 2020 33.81 Mn
Jun 30, 2020 33.81 Mn
Mar 31, 2020 -21.22 Mn
Mar 31, 2020 -21.22 Mn
Dec 31, 2019 -18.59 Mn
Dec 31, 2019 -18.59 Mn
Sep 30, 2019 14.30 Mn
Sep 30, 2019 14.30 Mn